title: From selection hits to clinical leads: progress in aptamer discovery.
abstract: Aptamers were discovered more than 25 years ago, yet only one has been approved by the US Food and Drug Administration to date. With some noteworthy advances in their chemical design and the enzymes we use to make them, aptamers and aptamer-based therapeutics have seen a resurgence in interest. New aptamer drugs are being approved for clinical evaluation, and it is certain that we will see increasingly more aptamers and aptamer-like drugs in the future. In this review, we will discuss the production of aptamers with an emphasis on the advances and modifications that enabled early aptamers to succeed in clinical trials as well as those that are likely to be important for future generations of these drugs.
authors.affiliation: Department of Biochemistry, Albert Einstein College of Medicine , Bronx, New York, USA.
authors.forename: Keith E
authors.initials: KE
authors.lastname: Maier
authors.affiliation: Department of Biochemistry, Albert Einstein College of Medicine , Bronx, New York, USA.
authors.forename: Matthew
authors.initials: M
authors.lastname: Levy